 |
Cramer's Mad Money - Hey Big Spenders (11/5/09) |
Yesterday
|
 |
|
Monday's Rx-Recap (11-02-09) |
11/03/2009
|
|
|
Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 |
11/03/2009
|
|
|
BenchmarkJournal.com Issues Independent Review on FINL, FSLR, EWBC, FITB, BARE and DNDN |
11/03/2009
|
 |
|
Dendreon Completes Submission of Biologics License Application for PROVENGE |
11/02/2009
|
 |
|
Dendreon to Hold Conference Call on Wednesday, November 11, 2009 at 4:30 PM ET |
10/30/2009
|
|
|
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences |
10/29/2009
|
|
|
Upgrades: DNDN, DO, PNC |
10/23/2009
|
 |
|
BID, DGX, FO, CNW, DNDN and LAMR Receiving Professional Financial Coverage from RothmanResearch.com |
10/23/2009
|
|
|
25 Option Write Ideas for October's Expiration Friday |
10/16/2009
|
|
|
25 High-Yielding Buy-Writes for October Options Expiration |
10/14/2009
|
|
|
Dendreon: New Board Members Appointed, Things Have Never Looked Brighter |
10/12/2009
|
|
|
Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors |
10/12/2009
|
|
|
Stock Watch: BDSI, ACTC.PK, ONTY |
10/11/2009
|
|
|
OncoGenex: Room for Further Growth? |
10/08/2009
|
|
$0.83 (2.99%)
03:04PM (15 mins delay)
